Comparison

Anti-Mouse CD73 - Purified in vivo GOLD™ Functional Grade

Item no. LEIN-C2413-50mg
Manufacturer Leinco Technologies
Amount 50 mg
Quantity options 0.5 mg 1 mg 100 mg 25 mg 50 mg 5 mg
Category
Type Antibody Monoclonal
Specific against other
ECLASS 10.1 42030590
ECLASS 11.0 42030590
UNSPSC 12352203
Shipping Condition Cool pack
Available
Manufacturer - Category
Purified in vivo Functional Grade>Gold Purified Bulk Antibodies|Primary Monoclonal Antibodies>Surfacetag Mouse CD Markers
Manufacturer - Targets
CD73
Shipping Temperature
2 - 8°C Wet Ice
Storage Conditions
Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
Product Description
CD73 is a 69 kDa cell-surface protein anchored to the membrane by a GPI (glycosylphosphatidylinositol) anchor. CD73 plays a vital role in modulating the immune response by converting AMP (adenosine monophosphate) to adenosine. This conversion shifts the environment from being pro-inflammatory to anti-inflammatory. CD73 is particularly involved in the immunosuppressive activity of regulatory T cells. It catalyzes the dephosphorylation of extracellular nucleoside 5' monophosphates to nucleosides1, 2. CD73 is expressed on specific subsets of T and B lymphocytes, with the highest expression found on B cells and CD8+ T cells. It is also implicated in cell activation, lymphocyte homing, and cell adhesion3. Moreover, CD73 has protective functions in various organ systems and cell types. For instance, it plays anti-nociceptive roles in the central nervous system and barrier-preserving roles in the respiratory system4.
The TY/23 clone has been demonstrated to inhibit the enzymatic activity of CD73. Therefore, it is a valuable tool for studying the role of CD73 in immune regulation and its potential as a therapeutic target5. This clone has been utilized for both in vivo and in vitro CD73 blockade, contributing significantly to our understanding of how CD73 impacts immune responses and tumor microenvironments6. CD73 is a key player in the tumor microenvironment, and inhibiting its activity has been suggested as a potential strategy for cancer immunotherapy7. Tumors exploit CD73 to generate adenosine, which then suppresses T-cell responses against the tumor. By targeting CD73 and inhibiting its function, it is believed that tumorigenesis can be reduced, and T-cell-directed therapies can be enhanced8.
Concentration
≥ 5.0 mg/ml
Formulation
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
Antigen Distribution
CD73 is expressed on subsets of T and B lymphocytes, with the highest expression
on B cells and CD8+ T cells.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close